Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001209191-19-050699

President and CEO acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

KANE MATTHEW R. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-09-23 Exercise or conversion : show line 1 in the form +10,000 $1.18 $11,800 1,812,427 D

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-09-23 Exercise or conversion : show line 2 in the form Employee Stock Option (Right to Buy) −10,000 $1.18 2027-03-23 10,000 13,422 D
2019-09-23 Grant or award : show line 3 in the form Employee Stock Option (Right to Buy) +262,252 $9.46 2029-09-22 262,252 262,252 D
Loading xslF345X03/doc4.xml…